 |
 |

Platelet Monoamine Oxidase in Affective Disorders
David J. Edwards, PhD;
Duane G. Spiker, MD;
David J. Kupfer, MD;
F. Gordon Foster, MD;
John F. Neil, MD;
Leatrice Abrams
Arch Gen Psychiatry. 1978;35(12):1443-1446.
Abstract
Platelet monoamine oxidase (MAO) activity was determined with tryptamine as substrate for 61 drug-free patients who had a primary major depressive disorder and for 32 normal controls. Although there were no significant differences between the mean platelet MAO activity of 19 bipolar patients (4.94 nmoles/hr/mg of protein), 42 unipolar patients (4.97 nmoles), and the controls (4.78 nmoles), an analysis of variance indicated that the variance of the bipolar group was significantly greater than that of the other groups. This suggests that there may be subgroups of bipolar patients that differ in their platelet MAO activity but that appear to be distinct from the bipolar I vs bipolar II classification.
Author Affiliations
From the Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic.
Footnotes
Accepted for publication June 18, 1978.
Reprint requests to Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15261 (Dr Edwards).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Platelet Monoamine Oxidase Activity and the Classification of Depression
Davidson et al.
Arch Gen Psychiatry 1980;37:771-773.
ABSTRACT
Toward the Validation of RDC Schizoaffective Disorder
Rosenthal et al.
Arch Gen Psychiatry 1980;37:804-810.
ABSTRACT
|